These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 558637)

  • 1. Imidazole: a selective inhibitor of thromboxane synthetase.
    Moncada S; Bunting S; Mullane K; Thorogood P; Vane JR; Raz A; Needleman P
    Prostaglandins; 1977 Apr; 13(4):611-8. PubMed ID: 558637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin endoperoxide and thromboxane generating systems and their selective inhibition.
    Moncada S; Needleman P; Bunting S; Vane JR
    Prostaglandins; 1976 Sep; 12(3):323-35. PubMed ID: 968048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-0164 inhibits generation of thromboxane-A2-like activity from prostaglandin endoperoxides by human platelet microsomes.
    Kulkarni PS; Eakins KE
    Prostaglandins; 1976 Sep; 12(3):465-9. PubMed ID: 968059
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: Formation of prostaglandin endoperoxides and rabbit aorta contracting substance (RCS) by coupling two enzyme systems.
    Bunting S; Moncada S; Needleman P; Vane JR
    Br J Pharmacol; 1976 Mar; 56(3):344P-345P. PubMed ID: 944058
    [No Abstract]   [Full Text] [Related]  

  • 5. Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets.
    Needleman P; Raz A; Ferrendelli JA; Minkes M
    Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1716-20. PubMed ID: 193113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides.
    Needleman P; Moncada S; Bunting S; Vane JR; Hamberg M; Samuelsson B
    Nature; 1976 Jun; 261(5561):558-60. PubMed ID: 934294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibitory actions of sodium-p-benzyl-4-[1-oxo-2-(4-chlorobenzyl)-3-phenyl propyl] phenyl phosphonate (N-0161) and indomethacin on the biosynthesis of prostaglandins and thromboxanes from arachidonic acid.
    Eakins KE; Kulkarni PS
    Br J Pharmacol; 1977 May; 60(1):135-40. PubMed ID: 884384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.
    Gryglewski RJ; Bunting S; Moncada S; Flower RJ; Vane JR
    Prostaglandins; 1976 Nov; 12(5):685-713. PubMed ID: 824685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboxanes: selective biosynthesis and distinct biological properties.
    Needleman P; Minkes M; Raz A
    Science; 1976 Jul; 193(4248):163-5. PubMed ID: 945611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Y-20811, a long-lasting thromboxane synthetase inhibitor, on thromboxane production and platelet function.
    Mikashima H; Ochi H; Muramoto Y; Yasuda H; Tsuruta M; Maruyama Y
    Thromb Res; 1986 Aug; 43(4):455-68. PubMed ID: 3094191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboxane synthetase inhibitors as pharmacological tools: differential biochemical and biological effects on platelet suspensions.
    Needleman P; Bryan B; Wyche A; Bronson SD; Eakins K; Ferrendelli JA; Minkes M
    Prostaglandins; 1977 Nov; 14(5):897-907. PubMed ID: 594391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversion of prostaglandin endoperoxide metabolism by selective inhibition of thromboxane A2 biosynthesis in lung, spleen or platelets.
    Nijkamp FP; Moncada S; White HL; Vane JR
    Eur J Pharmacol; 1977 Jul; 44(2):179-86. PubMed ID: 407090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin endoperoxides and thromboxanes: role in platelets and in vascular and respiratory smooth muscle.
    Samuelsson B
    Acta Biol Med Ger; 1976; 35(8-9):1055-63. PubMed ID: 1007751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway.
    Tobias LD; Hamilton JG
    Adv Prostaglandin Thromboxane Res; 1980; 6():453-6. PubMed ID: 6770605
    [No Abstract]   [Full Text] [Related]  

  • 15. 3-(1-imidazolylmethyl) indoles: potent and selective inhibitors of human blood platelet thromboxane synthetase.
    Cross PE; Dickinson RP; Parry MJ; Randall MJ
    Agents Actions; 1981 May; 11(3):274-80. PubMed ID: 7020379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparative HPLC purification of prostaglandin endoperoxides and isolation of novel cyclooxygenase-derived arachidonic acid metabolites.
    Hecker M; Hatzelmann A; Ullrich V
    Biochem Pharmacol; 1987 Mar; 36(6):851-5. PubMed ID: 3105538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human platelet thromboxane synthetase by 9,11-azoprosta-5,13-dienoic acid.
    Gorman RR; Bundy GL; Peterson DC; Sun FF; Miller OV; Fitzpatrick FA
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):4007-11. PubMed ID: 269449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthesis of thromboxane B2 and 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets. Evidence for a common enzymatic pathway.
    Raz A; Aharony D; Kenig-Wakshal R
    Eur J Biochem; 1978 May; 86(2):447-54. PubMed ID: 658053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of imidazole and 9,11-azoprosta-5,13-dienoic acid. Two selective thromboxane synthetase inhibitors.
    Fitzpatrick FA; Gorman RR
    Biochim Biophys Acta; 1978 Mar; 539(2):162-72. PubMed ID: 629996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the mechanism of prostacyclin and thromboxane A2 biosynthesis.
    Hecker M; Ullrich V
    J Biol Chem; 1989 Jan; 264(1):141-50. PubMed ID: 2491846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.